𝛼SK or Search

ENTITY

Tg Therapeutics (TGTX US)

3

Analysis

Health Care • United States

TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.

more

Refresh

Exchange Announcement • 06 Aug 2026 05:01

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 03 Aug 2026 19:05

Current Report (Form 8-K | Period ending 2026-08-03)

Exchange Announcement • 13 Jun 2026 04:32

Current Report (Form 8-K | Period ending 2026-06-11)

Exchange Announcement • 03 Jun 2026 19:34

Current Report (Form 8-K | Period ending 2026-06-03)

Exchange Announcement • 28 May 2026 04:34

Current Report (Form 8-K | Period ending 2026-05-27)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x